A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma
Condition(s):Renal Cancer MetastaticLast Updated:November 9, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):Renal Cancer MetastaticLast Updated:November 9, 2018Unknown status
Condition(s):Renal Cancer MetastaticLast Updated:February 28, 2023Recruiting
Condition(s):Metastatic Kidney Cancer; Metastatic Renal Cell CarcinomaLast Updated:January 29, 2014Terminated
Condition(s):Kidney NeoplasmsLast Updated:October 26, 2012Terminated
Condition(s):Metastatic Cancer; Metastatic Renal Cancer; Metastatic MelanomaLast Updated:October 28, 2015Terminated
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:February 15, 2013Completed
Condition(s):Renal Neoplasm With Metastasis; Response Evaluation Criteria in Solid TumorsLast Updated:April 24, 2020Unknown status
Condition(s):Clear Cell Renal CarcinomaLast Updated:November 13, 2020Completed
Condition(s):RCC; Metastatic Renal Cell CarcinomaLast Updated:March 26, 2024Recruiting
Condition(s):Metastatic Cancer; Metastatic Melanoma; Metastatic Renal CancerLast Updated:January 8, 2019Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.